EUVIMEDOpdag EUVIMED
Open access · CC BY 4.0

Master Regulator SMC1A, Stabilized by N6‐Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer–Promoter Interaction of Nestin

Zhenxiang Peng iD, Diguang Wen iD, Lu Zeng, Lin Lv iD, Shengtao Liao iD, Wenguang Zhang iD, Zhechuan Mei iD, Chuanfei Li iD

Advanced Science · 2026-08 · 13 (43)

DOI: 10.1002/advs.75616 ↗

At a glance

Journal article in Advanced Science, published online on 2026-05-22. Written by Zhenxiang Peng and 7 co-authors. Institution: Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China. Major MEDLINE topics: Liver Neoplasms, Carcinoma, Hepatocellular, Cell Cycle Proteins, Nestin. 97 references. The full text is freely available (open access, CC BY 4.0). Funded by: National Natural Science Foundation of China, General Project of Chongqing Natural Science Foundation, Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

HCC remains a leading cause of cancer‐related mortality, and effective therapies are limited. SMC1A, a core subunit of the cohesin complex involved in chromatin organization and transcriptional control, has not been fully characterized in HCC. SMC1A expression and prognostic value were analyzed using ICGC and single‐cell datasets, and validated in tissue microarrays and clinical specimens. Functional roles were examined in vitro, in vivo, and in patient‐derived organoids. Mechanistic studies combined transcriptomic, chromatin, and post‐transcriptional analyses to define downstream transcriptional regulation and upstream m6A‐dependent control. Therapeutic delivery was assessed using siRNA‐loaded LNPs. SMC1A was significantly upregulated in HCC and associated with poor prognosis. SMC1A knockdown suppressed proliferation, migration, invasion, and organoid growth, reduced tumor burden in xenograft and primary models, and promoted apoptosis. Nestin was identified as a transcriptional target of SMC1A; SMC1A facilitated enhancer–promoter interactions to activate Nestin transcription, and Nestin overexpression rescued malignant phenotypes after SMC1A depletion. Upstream, IGF2BP1 bound m6A‐modified regions within the SMC1A 3′‐UTR, stabilized SMC1A mRNA, and maintained the SMC1A–Nestin axis. Systemic LNP‐siSMC1A accumulated in the liver and inhibited tumor growth. SMC1A drives HCC progression through Nestin‐associated chromatin regulation and is maintained by IGF2BP1‐mediated m6A stabilization. LNP‐based silencing of SMC1A suppresses HCC.

Subjects

MeSH terms (MEDLINE)

Liver NeoplasmsCarcinoma, HepatocellularCell Cycle ProteinsNestinChromosomal Proteins, Non-HistoneRNA-Binding ProteinsHumansAnimalsStructural Maintenance of Chromosome Protein 1MiceGene Expression Regulation, NeoplasticPromoter Regions, GeneticDisease ProgressionCell Line, TumorCell ProliferationFemale

Author keywords

IGF2BP1NestinSMC1Aenhancerhepatocellular carcinomalipid nanoparticlesm6A

Substances

Cell Cycle ProteinsNestinChromosomal Proteins, Non-HistoneRNA-Binding ProteinsStructural Maintenance of Chromosome Protein 1IGF2BP1 protein, humanNES protein, human

Authors and institutions

  • Gastroenterology, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Chongqing Municipal Health Commission Key Laboratory of Precision Diagnosis and Treatment of Liver Cirrhosis and Complications, The Second Affiliated Hospital of Chongqing Medical University, Chongqing, China.
  • Gastroenterology, Affiliated Banan Hospital of Chongqing Medical University, Chongqing, China.

ORCID profiles: Zhenxiang Peng, Diguang Wen, Lin Lv, Shengtao Liao, Wenguang Zhang, Zhechuan Mei, Chuanfei Li

Funding

  • National Natural Science Foundation of China
  • General Project of Chongqing Natural Science Foundation
  • Kuanren Talents Program of the Second Affiliated Hospital of Chongqing Medical University
  • Open Project (General Project) of the Key Laboratory of Chongqing Municipal Health Commission for Science and Technology Joint Medical Research
  • the Medical Science and Technology Research Program of Chongqing Banan Science and Technology Bureau and Chongqing Banan Health Commission
  • Natural Science Foundation of Chongqing
  • Natural Science Foundation of Chongqing Municipality

Cite

APA

Peng, Z., Wen, D., Zeng, L., Lv, L., Liao, S., Zhang, W., Mei, Z., & Li, C. (2026). Master Regulator SMC1A, Stabilized by N6‐Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer–Promoter Interaction of Nestin. Advanced Science, 13(43). https://doi.org/10.1002/advs.75616

Vancouver

Peng Z, Wen D, Zeng L, Lv L, Liao S, Zhang W, et al. Master Regulator SMC1A, Stabilized by N6‐Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer–Promoter Interaction of Nestin. Advanced Science. 2026;13(43). doi:10.1002/advs.75616

BibTeX
@article{Peng2026,
  author = {Peng, Zhenxiang and Wen, Diguang and Zeng, Lu and Lv, Lin and Liao, Shengtao and Zhang, Wenguang and Mei, Zhechuan and Li, Chuanfei},
  title = {Master Regulator SMC1A, Stabilized by N6‐Methyladenosine Reader IGF2BP1, Promotes HCC Progression Through Facilitating Enhancer–Promoter Interaction of Nestin},
  journal = {Advanced Science},
  year = {2026},
  volume = {13},
  number = {43},
  doi = {10.1002/advs.75616}
}
Start for free →